1. Home
  2. SFHG vs INTS Comparison

SFHG vs INTS Comparison

Compare SFHG & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Samfine Creation Holdings Group Limited Ordinary Share

SFHG

Samfine Creation Holdings Group Limited Ordinary Share

HOLD

Current Price

$2.46

Market Cap

9.5M

ML Signal

HOLD

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$4.42

Market Cap

11.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SFHG
INTS
Founded
1993
2012
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Publishing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5M
11.4M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
SFHG
INTS
Price
$2.46
$4.42
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$38.00
AVG Volume (30 Days)
56.6K
38.1K
Earning Date
10-30-2025
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.32
$0.22
52 Week High
$3.17
$8.06

Technical Indicators

Market Signals
Indicator
SFHG
INTS
Relative Strength Index (RSI) 49.33 47.20
Support Level $2.26 $3.95
Resistance Level $2.64 $5.00
Average True Range (ATR) 0.19 0.34
MACD -0.00 0.01
Stochastic Oscillator 60.00 31.45

Price Performance

Historical Comparison
SFHG
INTS

About SFHG Samfine Creation Holdings Group Limited Ordinary Share

Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.

Share on Social Networks: